Clinical Trials · NCT00055731
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- UNICANCER
- Enrollment
- 413
- Start date
- Nov 2002
- Locations
- 38 sites, France
- Primary endpoint
- Progression-free survival